Citation: Ml. Cross et al., Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria?, INT IMMUNO, 1(5), 2001, pp. 891-901
Citation: Ml. Cross et Hs. Gill, Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies?, INT A AL IM, 125(2), 2001, pp. 112-119
Citation: J. Alfaro-adrian et al., Should total hip arthroplasty femoral components be designed to subside? Aradiostereometric analysis study of the Charnley Elite and Exeter stems, J ARTHROPLA, 16(5), 2001, pp. 598-606
Citation: Yh. Sheih et al., Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001, J AM COL N, 20(2), 2001, pp. 149-156
Citation: Q. Shu et Hs. Gill, A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity ofEscherichia coli O157 : H7 infection in mice, MED MICROBI, 189(3), 2001, pp. 147-152
Citation: Q. Shu et al., Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a pigletmodel, J PED GASTR, 33(2), 2001, pp. 171-177
Citation: Hs. Gill et Kj. Rutherfurd, Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20 (TM)) on leucocyte phagocytosis, NUTR RES, 21(1-2), 2001, pp. 183-189
Citation: Pk. Gopal et al., In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli, INT J F MIC, 67(3), 2001, pp. 207-216
Citation: Js. Zhou et al., Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do notdegrade gastric mucin in vitro, INT J F MIC, 63(1-2), 2001, pp. 81-90
Authors:
Shu, Q
Bird, SH
Gill, HS
Duan, E
Xu, Y
Hillard, MA
Rowe, JB
Citation: Q. Shu et al., Antibody response in sheep following immunization with Streptococcus bovisin different adjuvants, VET RES COM, 25(1), 2001, pp. 43-54
Citation: M. Harmjanz et al., New methodologies for the preparation of porphodimethenes and their conversion to trans-porphyrins with functionalized naphthyl spacers, J ORG CHEM, 66(16), 2001, pp. 5374-5383
Citation: Hs. Gill et Kj. Rutherfurd, Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice, BR J NUTR, 86(2), 2001, pp. 285-289
Citation: Hs. Gill et D. Eisenberg, The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition, BIOCHEM, 40(7), 2001, pp. 1903-1912
Authors:
Gill, HS
Rutherfurd, KJ
Cross, ML
Gopal, PK
Citation: Hs. Gill et al., Enhancement of immunity in the elderly by dietary supplementation with theprobiotic Bifidobacterium lactis HN019, AM J CLIN N, 74(6), 2001, pp. 833-839
Citation: Q. Shu et al., Immunization with a Streptococcus bovis vaccine administered by different routes against lactic acidosis in sheep, VET J, 159(3), 2000, pp. 262-269
Citation: K. Arunachalam et al., Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019), EUR J CL N, 54(3), 2000, pp. 263-267
Citation: Bl. Chiang et al., Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses, EUR J CL N, 54(11), 2000, pp. 849-855
Citation: Ms. Sachdev et al., A busbar protection technique and its performance during CT saturation andCT ratio-mismatch, IEEE POW D, 15(3), 2000, pp. 895-901
Citation: Q. Shu et al., Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice, MICROB IMMU, 44(4), 2000, pp. 213-222
Citation: Ts. Sidhu et al., A numerical technique based on symmetrical components for protecting three-winding transformers, ELEC POW SY, 54(1), 2000, pp. 19-28